Neuroone Medical Technologies Corp - Understand $nmtc stock

$NMTC Market Cap: $19.68 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$3.181M

TTM

Gross Margin

29.91%

TTM

Net Earnings

-$8.968M

TTM

Current Assets

$4.631M

Q3 2024

Current Liabilities

$2.213M

Q3 2024

Current Ratio

209.24%

Q3 2024

Total Assets

$5.370M

Q3 2024

Total Liabilities

$4.548M

Q3 2024

Book Value

$822.0K

Q3 2024

Cash

$1.460M

Q3 2024

P/E

-2.195

Nov 29, 2024 EST

Free Cash Flow

-$8.428M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009
Revenue	$3.453M	$1.952M	$171.2K	$243.0K		$0.00	$0.00	$0.00	$0.00	$0.00	$773.00	$1.249K	$0.00	$10.00K	$0.00	$0.00
YoY Change	76.86%	1040.65%	-29.55%							-100.0%	-38.11%		-100.0%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2024	2023	2022	2021	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009
Revenue	$3.453M	$1.952M	$171.2K	$243.0K	$0.00	$0.00	$0.00	$0.00	$0.00	$773.00	$1.249K	$0.00	$10.00K	$0.00	$0.00
Cost Of Revenue	$2.373M	$1.496M	$242.0K	$275.9K							$0.00	$0.00	$0.00	$0.00	$0.00
Gross Profit	$1.080M	$456.5K	-$70.79K	-$32.94K							$0.00	$0.00	$0.00	$0.00	$0.00
Gross Profit Margin	31.27%	23.38%	-41.36%	-13.56%							0.0%		0.0%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009
Selling, General & Admin	$7.902M	$6.926M	$6.979M	$6.260M	$4.753M	$4.284M	$2.677M	$2.337M	$32.61K	$30.00K	$40.00K	$30.00K	$10.00K	$30.00K	$10.00K	$0.00
YoY Change	14.08%	-0.76%	11.49%	31.71%	10.94%	60.05%	14.54%	7066.48%	8.7%	-25.0%	33.33%	200.0%	-66.67%	200.0%
% of Gross Profit	731.86%	1517.2%
Research & Development	$5.065M	$6.941M	$4.929M	$3.925M	$2.076M	$1.529M	$715.1K	$735.3K
YoY Change	-27.02%	40.8%	25.59%	89.09%	35.74%	113.85%	-2.75%
% of Gross Profit	469.14%	1520.36%
Depreciation & Amortization	$224.5K	$199.3K	$118.6K	$80.75K	$47.61K	$27.57K	$16.29K	$17.63K
YoY Change	12.65%	67.99%	46.9%	69.61%	72.69%	69.24%	-7.6%
% of Gross Profit	20.79%	43.65%
Operating Expenses	$12.97M	$13.87M	$11.91M	$10.19M	$6.829M	$5.813M	$3.392M	$3.072M	$32.61K	$30.92K	$36.69K	$26.34K	$10.00K	$30.00K	$10.00K	$0.00
YoY Change	-6.49%	16.44%	16.92%	49.15%	17.47%	71.39%	10.4%	9321.15%	5.49%	-15.73%	39.27%	163.42%	-66.67%	200.0%
Operating Profit	-$11.89M	-$11.96M	-$10.03M	-$10.22M	-$6.829M				-$32.61K	-$30.92K	-$35.91K	-$25.09K	-$10.00K	-$30.00K	-$10.00K	$0.00
YoY Change	-0.57%	19.19%	-1.83%	49.63%					5.49%	-13.92%	43.12%	150.93%	-66.67%	200.0%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2024	2023	2022	2021	2020	2019	2018	2017	2015	2014	2013	2012	2011	2010	2009
Interest Expense				-$1.080K	-$6.720M	-$414.3K	-$426.5K	-$1.635M	$14.02K	$330.00			$0.00
YoY Change				-99.98%	1521.95%	-2.85%	-73.92%		4147.88%
% of Operating Profit
Other Income/Expense, Net	$125.2K	$95.76K	$31.15K	$271.1K							-$5.461K	$0.00		$0.00	$0.00
YoY Change	30.72%	207.41%	-88.51%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009
Pretax Income	-$12.32M	-$11.86M	-$10.00M		-$13.64M	-$6.781M	-$5.133M	-$5.058M	-$32.61K	-$30.92K	-$36.24K	-$30.55K	-$10.00K	-$30.00K	-$10.00K	$0.00
YoY Change	3.87%	18.6%			101.15%	32.11%	1.47%	15411.42%	5.49%	-14.7%	18.62%	205.54%	-66.67%	200.0%
Income Tax								$0.00	$0.00	$0.00	$0.00		$0.00	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$12.32M	-$11.86M	-$10.00M	-$9.948M	-$13.64M	-$6.781M	-$5.133M	-$5.058M	-$47.78K	-$62.86K	-$36.24K	-$30.55K	-$13.96K	-$27.60K	-$6.044K	$0.00
YoY Change	3.87%	18.6%	0.52%	-27.07%	101.15%	32.11%	1.47%	10488.03%	-24.0%	73.44%	18.62%	118.87%	-49.43%	356.72%
Net Earnings / Revenue	-356.74%	-607.42%	-5841.95%	-4094.57%							-4688.75%	-2446.28%		-276.04%
Basic Earnings Per Share	-$0.46	-$0.65	-$0.63	-$0.93
Diluted Earnings Per Share	-$0.46	-$0.65	-$0.63	-$930.0K	-$2.519M	-$1.716M	-$1.829M	-$2.296M	-$28.26K	-$0.02	-$7.890K	-$5.917K	-$1.972K	-$6.466K	-$2.331K	$0.00

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009
Cash & Short-Term Investments	$5.322M	$11.14M	$6.901M	$4.036M	$260.7K	$13.26K	$26.47K	$522.2K	$0.00
YoY Change	-52.23%	61.44%	70.98%	1448.0%	1866.44%	-49.91%	-94.93%
Cash & Equivalents
Short-Term Investments	$0.00	$2.981M
Other Short-Term Assets	$263.8K	$296.7K	$244.0K	$118.6K	$41.00K	$5.380K	$7.150K	$53.82K	$1.840K	$0.00	$0.00	$0.00	$10.00K	$10.00K	$0.00
YoY Change	-11.09%	21.56%	105.75%	189.29%	662.08%	-24.76%	-86.71%	2825.0%				-100.0%	0.0%
Inventory	$1.727M	$704.5K	$98.29K
Prepaid Expenses
Receivables	$0.00	$33.24K	$48.34K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$7.313M	$12.18M	$7.292M	$4.155M	$301.8K	$18.64K	$33.61K	$576.0K	$1.840K	$0.00	$0.00	$0.00	$10.00K	$10.00K	$0.00
YoY Change	-39.94%	66.97%	75.5%	1276.97%	1518.83%	-44.54%	-94.17%	31206.52%				-100.0%	0.0%
Property, Plant & Equipment	$694.8K	$535.0K	$512.3K	$448.2K	$52.03K
YoY Change	29.88%	4.43%	14.29%	761.5%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$784.4K	$646.9K	$646.5K	$604.8K	$230.9K	$200.1K	$216.4K	$180.9K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change	21.26%	0.06%	6.9%	161.95%	15.39%	-7.53%	19.62%
Total Assets	$8.097M	$12.82M	$7.939M	$4.760M	$532.6K	$218.7K	$250.0K	$756.9K	$1.840K	$0.00	$0.00	$0.00	$10.00K	$10.00K	$0.00
YoY Change
Accounts Payable	$685.1K	$927.7K	$528.8K	$762.5K	$1.152M	$221.2K			$10.86K	$10.00K	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change	-26.15%	75.42%	-30.65%	-33.83%	420.91%				8.6%
Accrued Expenses	$1.108M	$715.8K	$644.3K	$512.8K	$617.7K	$1.591M	$1.022M	$264.3K		$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change	54.72%	11.11%	25.64%	-16.99%	-61.17%	55.74%	286.48%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00	$1.007M	$0.00	$1.677M	$2.421M	$275.2K	$0.00	$0.00	$30.00K	$20.00K	$0.00	$0.00	$0.00
YoY Change			-100.0%		-100.0%	-30.75%	779.85%			-100.0%	50.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.793M	$3.099M	$1.182M	$2.356M	$1.770M	$3.797M	$3.905M	$677.2K	$83.33K	$40.00K	$30.00K	$20.00K	$0.00	$0.00	$0.00
YoY Change	-42.15%	162.22%	-49.84%	33.09%	-53.38%	-2.76%	476.67%	712.66%	108.33%	33.33%	50.0%
Long-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$817.2K	$1.381M	$346.0K	$0.00	$0.00	$0.00	$0.00	$10.00K	$10.00K	$0.00
YoY Change					-100.0%	-40.85%	299.31%					-100.0%	0.0%
Other Long-Term Liabilities	$55.28K	$119.6K	$202.9K	$337.7K
YoY Change	-53.76%	-41.07%	-39.91%
Total Long-Term Liabilities	$55.28K	$119.6K	$202.9K	$337.7K	$0.00	$817.2K	$1.381M	$346.0K	$0.00	$0.00	$0.00	$0.00	$10.00K	$10.00K	$0.00
YoY Change	-53.76%	-41.07%	-39.91%		-100.0%	-40.85%	299.31%					-100.0%	0.0%
Total Liabilities	$1.848M	$3.218M	$1.385M	$2.694M	$1.770M	$4.615M	$5.287M	$1.023M	$83.33K	$40.00K	$30.00K	$20.00K	$20.00K	$10.00K	$0.00
YoY Change	-42.58%	132.43%	-48.6%	52.16%	-61.64%	-12.71%	416.7%	1127.83%	108.33%	33.33%	50.0%	0.0%	100.0%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2024	2023	2022	2021
Basic Shares Outstanding	26.76M shares	18.12M shares	16.00M shares	10.70M shares
Diluted Shares Outstanding	26.76M shares	18.12M shares	16.00M shares	10.70M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $19.68 Million

About NEUROONE MEDICAL TECHNOLOGIES Corp

NeuroOne Medical Technologies Corp. is a medical technology company, which engages in the development and commercialization of thin film electrode technology for continuous electroencephalogram and stereoelectrocencephalography recording, spinal cord stimulation, brain stimulation, and ablation solutions. The company is headquartered in Eden Prairie, Minnesota and currently employs 16 full-time employees. The company went IPO on 2012-11-09. The firm is focused on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, spinal cord stimulation, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. The company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure and artificial intelligence. Its Evo cortical electrode technology records, monitors, and stimulates brain tissue on the surface of the brain. Its products include strip/grid, depth electrodes (sEEG Products) and electrode cable assembly products.

Industry: Surgical & Medical Instruments & Apparatus Peers: ABBOTT LABORATORIES BioSig Technologies, Inc. DELCATH SYSTEMS, INC. Sonendo, Inc. STRATA Skin Sciences, Inc. electroCore, Inc. OMNIA WELLNESS INC. MINERVA SURGICAL INC PRECISION OPTICS CORPORATION, INC. SANUWAVE Health, Inc.